SINOPHARM GROUP CO 18/06/2026 AGM
1Approval of the Board of Directors' Report for the Year Ended 31 December 2025For
2Approval of the Supervisory Committee's Report for the Year Ended 31 December 2025For
3Approval of the Audited Financial Statements and Auditors' Report for the Year Ended 31 December 2025For
4Approve the Dividend of RMB 0.69 Per ShareFor
5Authorisation of the Board to Determine Directors' Remuneration for 2026For
6Authorisation of the Supervisory Committee to Determine Supervisors' Remuneration for 2026For
7Appointment of Confucius International CPA Limited and Pan-China Certified Public Accountants LLP as Auditors of the Company and Allow the Board to Determine their RemunerationFor
8Delegation of Authority to the Board to Provide Guarantees for SubsidiariesFor
9Granting of a General Mandate to Issue New SharesFor
10Granting of a General Mandate to Repurchase H SharesFor
11Extension of the Validity Period of the Registration Notice for Non-Financial Corporate Debt Financing InstrumentsFor